1. Home
  2. CHEK vs ACON Comparison

CHEK vs ACON Comparison

Compare CHEK & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHEK
  • ACON
  • Stock Information
  • Founded
  • CHEK 2004
  • ACON 2008
  • Country
  • CHEK Israel
  • ACON United States
  • Employees
  • CHEK N/A
  • ACON N/A
  • Industry
  • CHEK Medical Electronics
  • ACON Retail: Computer Software & Peripheral Equipment
  • Sector
  • CHEK Health Care
  • ACON Technology
  • Exchange
  • CHEK Nasdaq
  • ACON Nasdaq
  • Market Cap
  • CHEK 3.9M
  • ACON 4.5M
  • IPO Year
  • CHEK 2015
  • ACON 2022
  • Fundamental
  • Price
  • CHEK $2.51
  • ACON $8.20
  • Analyst Decision
  • CHEK
  • ACON Buy
  • Analyst Count
  • CHEK 0
  • ACON 2
  • Target Price
  • CHEK N/A
  • ACON $481.00
  • AVG Volume (30 Days)
  • CHEK 8.8M
  • ACON 8.2K
  • Earning Date
  • CHEK 11-14-2025
  • ACON 11-13-2025
  • Dividend Yield
  • CHEK N/A
  • ACON N/A
  • EPS Growth
  • CHEK N/A
  • ACON N/A
  • EPS
  • CHEK N/A
  • ACON N/A
  • Revenue
  • CHEK N/A
  • ACON $62,948.00
  • Revenue This Year
  • CHEK N/A
  • ACON $145.39
  • Revenue Next Year
  • CHEK N/A
  • ACON $145.45
  • P/E Ratio
  • CHEK N/A
  • ACON N/A
  • Revenue Growth
  • CHEK N/A
  • ACON 16.68
  • 52 Week Low
  • CHEK $0.56
  • ACON $6.20
  • 52 Week High
  • CHEK $3.13
  • ACON $3,499.51
  • Technical
  • Relative Strength Index (RSI)
  • CHEK 85.70
  • ACON 70.92
  • Support Level
  • CHEK $0.65
  • ACON $7.00
  • Resistance Level
  • CHEK $3.13
  • ACON $7.84
  • Average True Range (ATR)
  • CHEK 0.27
  • ACON 0.32
  • MACD
  • CHEK 0.22
  • ACON 0.10
  • Stochastic Oscillator
  • CHEK 75.20
  • ACON 87.39

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

About ACON Aclarion Inc.

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.

Share on Social Networks: